Angiogenesis is important in the growth and progression of solid tumours. The main pro-
angiogenic factor, namely vascular endothelial growth factor (VEGF), also known as …

STUDY QUESTION Can controlled ovarian hyperstimulation (COH) for fertility preservation
be effectively conducted in women with breast cancer without worsening their prognosis …

Vascular endothelial growth factor (VEGF), a potent angiogenic factor, has been reported to
be associated with a poor prognosis in primary breast cancer and in several other cancer …

Vascular endothelial growth factor (VEGF) is a potent stimulator of angiogenesis and a
prognostic factor for many tumors including those of endocrine-responsive tissues such as …

Purpose To test whether combining bevacizumab, an anti–vascular endothelial growth
factor treatment, with endocrine therapy (ET) could potentially delay the emergence of …

Vascular endothelial growth factor (VEGF) is a major inducer of tumor angiogenesis and an
important prognostic factor in breast cancer. Hypoxia is an important inducer of VEGF …

The mammary gland life cycle is exemplified by massive, physiologically dictated changes in
cell number and composition, architecture, and functionality. These drastic upheavals, by …

Royal jelly (RJ) from honeybees (Apis mellifera) is traditionally thought to improve
menopausal symptoms. The potential estrogenic activities of RJ were investigated using …

Purpose: Androgen deprivation is implicated in reducing neoangiogenesis in prostate
cancer (PCA). Androgens regulate the expression of the vascular endothelial growth factor …

Postoperative radiotherapy, which forms part of breastconserving therapy, may not need to
encompass the whole breast. Apart from the consumption of huge resources and patients' …